PMGC (NASDAQ:ELAB) Shares to Reverse Split on Tuesday, January 6th

Shares of PMGC Holdings Inc. (NASDAQ:ELAB) are going to reverse split before the market opens on Tuesday, January 6th. The 1-4 reverse split was announced on Friday, January 2nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, January 5th.

PMGC Trading Down 4.1%

Shares of ELAB stock traded down $0.06 during midday trading on Friday, reaching $1.42. 478,161 shares of the stock were exchanged, compared to its average volume of 999,081. PMGC has a 1 year low of $1.25 and a 1 year high of $99.72. The firm has a market cap of $965,600.00, a PE ratio of -0.08 and a beta of 0.70. The company’s 50 day moving average is $4.34 and its two-hundred day moving average is $5.86.

PMGC (NASDAQ:ELAB) last announced its earnings results on Friday, November 14th. The company reported ($4.95) earnings per share for the quarter. The business had revenue of $0.29 million for the quarter.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Wall Street Zen upgraded PMGC to a “sell” rating in a research note on Saturday, October 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.